In September 2015, the Patent Trial and Appeal Board denied four more petitions by Stryker Corporation (SYK) for inter partes review of U.S. Patent Nos. 7,471,310, 7,821,530, 7,844,657, and 8,439,821, owned by Karl Storz Endoscopy-America, Inc. (IPR2015-00672, Paper 9; IPR2015-00674, Paper 9; IPR2015-00764, Paper 13; IPR2015-00679, Paper 9.) The PTAB also denied in part Stryker’s two petitions for IPR of KSEA’s U.S. Patent No. 8,069,420. (IPR2015-00677, Paper 15; IPR2015-00678, Paper 12.) The KARL STORZ patents are directed to video imaging systems (‘310 and ‘530 patents), systems for controlling medical devices in an operating room (‘657 and ‘821 patents), and systems for controlling the communication of medical imaging data (‘420 patent). KARL STORZ commercializes the technology and Stryker is one of its competitors.
By Hao Zhang and Patrick D. Duplessis U.S. inventors seeking to protect their IP rights worldwide often file foreign patent applications in markets where they conduct business or where they are likely to find infringers [Read More…]
The Federal Circuit recently provided insight into the complicated issue of § 101 subject matter eligibility for method of treatment claims. In Vanda Pharmaceuticals Inc v West-Ward Pharmaceuticals, 887 F.3d. 1117 (Fed. Cir. 2018), a [Read More…]
On July 17, the WHIPgroup Tech Entrepreneur Meetup will return to the important topic of Artificial Intelligence. We will hear from the co-founders of Dreyev (pronounced “drive”), an interactive driving safety system that combines AI with [Read More…]